Development and validation of a method for the determination of the specific activity of recombinant monoclonal antibody eculizumab
Objectives. Developing reliable and accurate analytical methods is necessary for comparative pharmaceutical analysis using physicochemical, biological (in vitro), preclinical, and clinical trials. The main objective of this study was to develop and validate an in vitro method for determining the spe...
Saved in:
| Main Authors: | D. I. Zybin, A. S. Seregin, A. D. Askretkov, N. V. Orlova, Yu. A. Seregin, A. I. Prostyakova, D. V. Kapustin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
MIREA - Russian Technological University
2020-05-01
|
| Series: | Тонкие химические технологии |
| Subjects: | |
| Online Access: | https://www.finechem-mirea.ru/jour/article/view/1599 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment
by: Cameron Perry, et al.
Published: (2025-06-01) -
Striving for excellence in paroxysmal nocturnal hemoglobinuria in Canada: the EPIC program
by: Hayeong Rho, et al.
Published: (2025-07-01) -
Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency
by: Ting Wu, et al.
Published: (2025-08-01) -
Obtaining and Characterization of Hybridomas Producing Monoclonal Antibodies to Shiga-Like Toxins of I and II Types
by: G. V. Kuklina, et al.
Published: (2021-10-01) -
Obtaining and Characterization of Hybridomas Producing Monoclonal Antibodies against Coronavirus SARS-CоV-2
by: G. V. Kuklina, et al.
Published: (2023-05-01)